A biotechnology company developing t-cell immunotherapies therapies for the treatment of cancer. The company is headquartered in Singapore, and was founded by Malcolm Brenner and Andrew Khoo in 2011.
1
Funding Rounds
$80.0m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Ma***** Br***** | - | - | - |
Name | Phone | Social networks | |
---|---|---|---|
Je***** Bu******* | - | - |